Page last updated: 2024-11-12

5-dihydrocortisol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

5-dihydrocortisol: RN given refers to (5alpha,11beta)-isomer; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID12816693
CHEMBL ID1079111
CHEBI ID167505
SCHEMBL ID1566817
MeSH IDM0070942

Synonyms (27)

Synonym
516-41-6
CHEBI:167505
(5s,8s,9s,10s,11s,13s,14s,17r)-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-2,4,5,6,7,8,9,11,12,14,15,16-dodecahydro-1h-cyclopenta[a]phenanthren-3-one
5-dihydrocortisol
11,17,21-trihydroxypregnane-3,20-dione
5alpha-pregnane-11beta,17alpha,21 triol-3,20-dione
CHEMBL1079111
unii-364xcm54bs
11beta,17,21-trihydroxy-5alpha-pregnane-3,20-dione
allodihydrohydrocortisone
hydrallostane
pregnane-3,20-dione, 11,17,21-trihydroxy-, (5alpha,11beta)-
5alpha-dhf
allopregnane-11beta,17alpha,21-triol-3,20-dione
364xcm54bs ,
5alpha-pregnane-3,20-dione, 11beta,17,21-trihydroxy-
5alpha-dihydrocortisol
11beta,17alpha,21-trihydroxy-5alpha-pregnane-3,20-dione
allodihydrocortisol
allodihydro f
4,5.alpha.-dihydrocortisol
hydrallostane [mi]
(5.alpha.,11.beta.)-11,17,21-trihydroxypregnane-3,20-dione
SCHEMBL1566817
11-beta,17-alpha,21-trihydroxy-5-alpha-pregnane-3,20-dione
Q27256518
DTXSID101315934
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
21-hydroxy steroid
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID468984Inhibition of human 17beta-HSD7 expressed in HEK293 cells assessed as inhibition of reduction of [14C]estrone into [14C]estradiol at 0.3 uM after 7 hrs2009Journal of medicinal chemistry, Dec-10, Volume: 52, Issue:23
Potent and selective steroidal inhibitors of 17beta-hydroxysteroid dehydrogenase type 7, an enzyme that catalyzes the reduction of the key hormones estrone and dihydrotestosterone.
AID468985Inhibition of human 17beta-HSD7 expressed in HEK293 cells assessed as inhibition of reduction of [14C]estrone into [14C]estradiol at 3 uM after 7 hrs2009Journal of medicinal chemistry, Dec-10, Volume: 52, Issue:23
Potent and selective steroidal inhibitors of 17beta-hydroxysteroid dehydrogenase type 7, an enzyme that catalyzes the reduction of the key hormones estrone and dihydrotestosterone.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (10)

TimeframeStudies, This Drug (%)All Drugs %
pre-19907 (70.00)18.7374
1990's2 (20.00)18.2507
2000's1 (10.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.68

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.68 (24.57)
Research Supply Index2.40 (2.92)
Research Growth Index4.08 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.68)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other10 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]